Evaluating the Combined Anticancer Response of Checkpoint Inhibitor Immunotherapy and FAP-Targeted Molecular Radiotherapy in Murine Models of Melanoma and Lung Cancer

SIMPLE SUMMARY: Although newer cancer medicines that help the immune system recognize and attack cancer cells have improved responses to therapy, most patients ultimately have cancer recurrence. Additional therapies and therapy combinations are needed so that responses can last longer or indefinitel...

Descripción completa

Detalles Bibliográficos
Autores principales: Capaccione, Kathleen M., Doubrovin, Mikhail, Braumuller, Brian, Leibowitz, Dev, Bhatt, Nikunj, Momen-Heravi, Fatemeh, Molotkov, Andrei, Kissner, Michael, Goldner, Kimberly, Soffing, Mark, Ali, Alessandra, Mintz, Akiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559475/
https://www.ncbi.nlm.nih.gov/pubmed/36230500
http://dx.doi.org/10.3390/cancers14194575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559475/
https://www.ncbi.nlm.nih.gov/pubmed/36230500
http://dx.doi.org/10.3390/cancers14194575

Ejemplares similares